Synergistic Antiproliferative Effects of Co-nanoencapsulated Curcumin and Chrysin on MDA-MB-231 Breast Cancer Cells Through Upregulating miR-132 and miR-502c
- 7 April 2019
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 71 (7) , 1201-1213
Abstract
In this study, we explored whether co-nanoencapsulated Curcumin (Cur) and Chrysin (Chr), natural herbal compounds with antitumor activities, regulate miR-132 and miR-502c and their downstream targets, leading to the synergistic growth inhibition in MDA-MB-231 breast cancer cells. For this purpose, Cur and Chr were co-encapsulated into PLGA-PEG nanoparticles (NPs) and characterized through DLS, FTIR and FE-SEM. MTT assay and cell cycle arrest analysis revealed that CurChr-loaded NPs had a considerable synergistic cytotoxicity against MDA-MB-231 cells with more cell accumulation in G2/M phase compared to the other groups. In addition, highest percentage of cell apoptosis was acquired in cells treated with CurChr-loaded NPs according to apoptosis analysis. Real-time PCR findings revealed that co-encapsulated form of Cur and Chr than free combination could further upregulate miR-132 and miR-502c expression (P < 0.001). Also, the strong reduction was detected in the protein levels of HN1 and P65 at the cells co-nanodelivered with Cur and Chr. These findings demonstrated that the co-nanodelivery of Cur and Chr through targeting miR-132 and miR-205c might be a novel strategy for the treatment of breast cancer.Keywords
This publication has 56 references indexed in Scilit:
- miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down‐regulation of the inflammatory cytokines CXCL1 and ‐2Molecular Oncology, 2014
- MicroRNAs and other non-coding RNAs as targets for anticancer drug developmentNature Reviews Drug Discovery, 2013
- Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumorsCarcinogenesis, 2013
- Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDFJournal of Hematology & Oncology, 2012
- MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathwaysOncogene, 2011
- Curcumin Modulates MicroRNA-203–Mediated Regulation of the Src-Akt Axis in Bladder CancerCancer Prevention Research, 2011
- Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathwayBiochemical and Biophysical Research Communications, 2010
- Apoptotic Effects of Chrysin in Human Cancer Cell LinesInternational Journal of Molecular Sciences, 2010
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinomaNature, 2009
- Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancerMolecular Cancer Therapeutics, 2007